Report Detail

Pharma & Healthcare Global Pain Management Drugs Market Insights, Forecast to 2025

  • RnM3021506
  • |
  • 02 April, 2019
  • |
  • Global
  • |
  • 126 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
The classification of pain management drugs includes opioids, NSAIDs and other types, and the proportion of opioids is about 47% in 2016, and the proportion is in decreasing trend from 2012 to 2017.
North America is the largest consumption place, with a consumption market share nearly 37% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
Market competition is intense. Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Pain Management Drugs market is valued at 35600 million US$ in 2018 and will reach 43900 million US$ by the end of 2025, growing at a CAGR of 2.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pain Management Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Pain Management Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pain Management Drugs in these regions.
This research report categorizes the global Pain Management Drugs market by top players/brands, region, type and end user. This report also studies the global Pain Management Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue

Market size by Product
Generic Opioids
Branded Opioids
NSAIDs
Others
Market size by End User
Hospitals
Clinics
Drugstores

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pain Management Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pain Management Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pain Management Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pain Management Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pain Management Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pain Management Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Pain Management Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Pain Management Drugs Market Size Growth Rate by Product
      • 1.4.2 Generic Opioids
      • 1.4.3 Branded Opioids
      • 1.4.4 NSAIDs
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Pain Management Drugs Market Size Growth Rate by End User
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Drugstores
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Pain Management Drugs Market Size
      • 2.1.1 Global Pain Management Drugs Revenue 2014-2025
      • 2.1.2 Global Pain Management Drugs Sales 2014-2025
    • 2.2 Pain Management Drugs Growth Rate by Regions
      • 2.2.1 Global Pain Management Drugs Sales by Regions
      • 2.2.2 Global Pain Management Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Pain Management Drugs Sales by Manufacturers
      • 3.1.1 Pain Management Drugs Sales by Manufacturers
      • 3.1.2 Pain Management Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Pain Management Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Pain Management Drugs Revenue by Manufacturers
      • 3.2.1 Pain Management Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Pain Management Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Pain Management Drugs Price by Manufacturers
    • 3.4 Pain Management Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Pain Management Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Pain Management Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Pain Management Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Pain Management Drugs Sales by Product
    • 4.2 Global Pain Management Drugs Revenue by Product
    • 4.3 Pain Management Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Pain Management Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Pain Management Drugs by Countries
      • 6.1.1 North America Pain Management Drugs Sales by Countries
      • 6.1.2 North America Pain Management Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Pain Management Drugs by Product
    • 6.3 North America Pain Management Drugs by End User

    7 Europe

    • 7.1 Europe Pain Management Drugs by Countries
      • 7.1.1 Europe Pain Management Drugs Sales by Countries
      • 7.1.2 Europe Pain Management Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Pain Management Drugs by Product
    • 7.3 Europe Pain Management Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Pain Management Drugs by Countries
      • 8.1.1 Asia Pacific Pain Management Drugs Sales by Countries
      • 8.1.2 Asia Pacific Pain Management Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Pain Management Drugs by Product
    • 8.3 Asia Pacific Pain Management Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Pain Management Drugs by Countries
      • 9.1.1 Central & South America Pain Management Drugs Sales by Countries
      • 9.1.2 Central & South America Pain Management Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Pain Management Drugs by Product
    • 9.3 Central & South America Pain Management Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Pain Management Drugs by Countries
      • 10.1.1 Middle East and Africa Pain Management Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Pain Management Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Pain Management Drugs by Product
    • 10.3 Middle East and Africa Pain Management Drugs by End User

    11 Company Profiles

    • 11.1 Pfizer
      • 11.1.1 Pfizer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Pfizer Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Pfizer Pain Management Drugs Products Offered
      • 11.1.5 Pfizer Recent Development
    • 11.2 GSK
      • 11.2.1 GSK Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GSK Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GSK Pain Management Drugs Products Offered
      • 11.2.5 GSK Recent Development
    • 11.3 Grunenthal
      • 11.3.1 Grunenthal Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Grunenthal Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Grunenthal Pain Management Drugs Products Offered
      • 11.3.5 Grunenthal Recent Development
    • 11.4 Bayer
      • 11.4.1 Bayer Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Bayer Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Bayer Pain Management Drugs Products Offered
      • 11.4.5 Bayer Recent Development
    • 11.5 Sanofi
      • 11.5.1 Sanofi Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Sanofi Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Sanofi Pain Management Drugs Products Offered
      • 11.5.5 Sanofi Recent Development
    • 11.6 Eli Lilly
      • 11.6.1 Eli Lilly Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Eli Lilly Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Eli Lilly Pain Management Drugs Products Offered
      • 11.6.5 Eli Lilly Recent Development
    • 11.7 AstraZeneca
      • 11.7.1 AstraZeneca Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 AstraZeneca Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 AstraZeneca Pain Management Drugs Products Offered
      • 11.7.5 AstraZeneca Recent Development
    • 11.8 Endo
      • 11.8.1 Endo Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Endo Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Endo Pain Management Drugs Products Offered
      • 11.8.5 Endo Recent Development
    • 11.9 Merck
      • 11.9.1 Merck Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Merck Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Merck Pain Management Drugs Products Offered
      • 11.9.5 Merck Recent Development
    • 11.10 Depomed
      • 11.10.1 Depomed Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Depomed Pain Management Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Depomed Pain Management Drugs Products Offered
      • 11.10.5 Depomed Recent Development
    • 11.11 Yunnan Baiyao
    • 11.12 Teva
    • 11.13 J&J
    • 11.14 Allergan
    • 11.15 Purdue

    12 Future Forecast

    • 12.1 Pain Management Drugs Market Forecast by Regions
      • 12.1.1 Global Pain Management Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Pain Management Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Pain Management Drugs Market Forecast by Product
      • 12.2.1 Global Pain Management Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Pain Management Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Pain Management Drugs Market Forecast by End User
    • 12.4 North America Pain Management Drugs Forecast
    • 12.5 Europe Pain Management Drugs Forecast
    • 12.6 Asia Pacific Pain Management Drugs Forecast
    • 12.7 Central & South America Pain Management Drugs Forecast
    • 12.8 Middle East and Africa Pain Management Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Pain Management Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Pain Management Drugs . Industry analysis & Market Report on Pain Management Drugs is a syndicated market report, published as Global Pain Management Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Pain Management Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,120.00
      4,680.00
      6,240.00
      3,642.60
      5,463.90
      7,285.20
      615,966.00
      923,949.00
      1,231,932.00
      325,377.00
      488,065.50
      650,754.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report